9 results about "Before Meals" patented technology

The invention provides a diet data analysis method, system and device based on intelligent equipment, and aims to solve the problems that traditional diet analysis depends on manpower, recognition is single, dynamic states in meals are ignored, and food materials and cooking processes cannot be reversely deduced. Comprising the steps of pre-meal static multi-mode scanning, physical decoupling analysis, in-meal dynamic interaction analysis, cross-spatio-temporal data fusion and probability traceability. The system comprises the intelligent tableware integrated with multiple modules / sensors, a data processing unit for executing an algorithm and a result display unit for displaying a report. According to the method, the component identification precision and the nutrition estimation accuracy are improved, the whole-process accurate analysis of the diet data from before meal to during meal is realized, and reliable data support is provided for diet health management.

This invention discloses the application of a composition in the preparation of foods or medicines that reduce blood lead levels, belonging to the field of food or pharmaceutical applications. The composition is for improving intestinal microecology, comprising inulin, galactooligosaccharides, polydextrose, and water-insoluble dietary fiber, wherein the weight ratio of inulin, galactooligosaccharides, polydextrose, and water-insoluble dietary fiber is 25:25:20:30, and the composition is taken immediately after being dissolved in warm water before meals. This invention, through the rational combination of water-insoluble dietary fiber and functional polysaccharides, adjusts the release rate of nutrients in the intestine, slows down digestion, absorbs and eliminates toxic substances from food, reduces intestinal permeability, and simultaneously possesses the functions of water absorption and swelling, gradient adhesion, mechanical isolation, mesh adsorption, ion exchange, and microbial regulation, providing a favorable environment and food for the growth of intestinal microorganisms, and effectively reducing blood endotoxins and blood lead levels, enhancing immunity, and preventing chronic diseases.

The invention relates to a pharmaceutical composition kit for controlling blood sugar. The pharmaceutical composition kit comprises an oral insulin enteric capsule and a ketoester oral liquid or a ketoester capsule. The insulin enteric capsule is orally taken before sleep, so that fasting blood-glucose at night and in the morning can be well controlled. The ketoester oral liquid is taken before meals in daytime, so that a human body enters a ketogenic state, the blood sugar is reduced, and the postprandial blood sugar peak can be avoided. The combination of the two medicines can realize better control of human blood sugar. Furthermore, ketone ester can enhance insulin sensitivity and enhance the heart function of the diabetic patient. The kit is low in cost and good in sugar control effect, and is an ideal sugar control scheme for diabetics at present.

The utility model discloses a diet production pretreatment device which comprises a box body, an electric heating assembly arranged in the box body, a temperature controller arranged on the box body, a placing basket movably arranged in the box body, two first filter plates fixedly arranged in the box body, and a second filter plate fixedly arranged between the two first filter plates, a drain outlet is formed in one side of the box body, a pull rod is fixedly arranged on one side of the scraper, a plug body is arranged at one end of the pull rod, a cover body is hinged to the box body, water spraying pipes are arranged in the cover body, the number of the water spraying pipes is two, and the box body is connected with a pump body through a pipeline. The hose is connected between the pump body and the two water spraying pipes, frozen food can be subjected to spraying and unfreezing pretreatment before diet production, meanwhile, sprayed water can be filtered and heated as much as possible and then is rotated for use, and therefore resources are saved.

To provide a novel agent having an action of promoting urinary excretion of sugar.SOLUTION: Provided is an agent for promoting urinary excretion of sugar, the agent containing Dai-saiko-to or Bofu-tsusho-san. Also provided is an agent for promoting urinary excretion of sugar, the agent containing Dai-saiko-to and being used so as to be taken before meals. Also provided is an agent for promoting urinary excretion of sugar, the agent containing Bofu-tsusho-san and being used so as to be taken before meals. Further provided is an SGLT2 inhibitor that contains Dai-saiko-to or Bofu-tsusho-san.SELECTED DRAWING: Figure 3

Provided herein are product combinations, methods, kits, and compositions related to improving health and well-being in a subject. Methods of improving health and well-being may include ingesting a yerba mate supplement after waking, fasting for a fasting interval, and ingesting a fiber supplement before meal consumption.

A blood sugar monitoring and reminding device for a diabetic patient comprises a shell, and a control circuit and a power module are arranged in the shell; the input assembly is fixedly installed on the shell, the input assembly comprises keys and a touch sensor, and the input assembly is electrically connected to the control circuit and used for inputting signals in a pressing or touch mode before a patient has a meal; the timing assembly comprises a timing chip, and the timing chip is electrically connected to the control circuit and used for recording the input time of the input assembly and outputting a control signal after preset time; the device further comprises a reminding assembly, a blood glucose input assembly, a storage assembly and a display assembly. According to the utility model, the problem that blood sugar monitoring before and after meals is not timely due to forgetting of a patient is effectively solved.

The utility model relates to a meal box with a reminding function for diabetics, which comprises a box body with a containing cavity and a box cover capable of sealing the containing cavity, a reminding component and a placing groove are arranged outside the box cover, and the placing groove is used for placing an insulin pen storage box; the reminding assembly comprises a first sensor, a second sensor, a control panel and a voice module, the first sensor is arranged on the box cover, the second sensor is arranged in the containing groove, and the first sensor, the second sensor and the voice module are all electrically connected with the control panel. Through the arrangement of the meal box reminding module, whether a patient injects insulin or not before meals can be accurately judged by sensing the opening and closing actions of the box cover and the taking and placing actions of an insulin pen, reminding is given out in time, the time of the patient after meals can be accurately judged, and therefore reminding for measuring blood sugar can be given out after the patient has meals and two hours after the patient has meals; a patient is helped to complete insulin injection and blood glucose measurement on time.

The invention provides a temozolomide lipid composition as well as a preparation method and application thereof. The temozolomide lipid composition comprises temozolomide, a fat-soluble solvent, phospholipid, vitamin E polyethylene glycol succinate, an osmotic pressure regulator, a pH regulator and water. In the temozolomide lipid composition, the mass volume percent of temozolomide is 1%-9%; the mass volume percentage of the fat-soluble solvent is 10%-70%; the mass volume percent of the phospholipid is 1%-3%; the mass volume percent of the vitamin E polyethylene glycol succinate is 0.5%-5%; the mass volume percent of the osmotic pressure regulator is 0.5%-10%; the pH value of the temozolomide lipid composition is 2 to 6; the fat-soluble solvent contains oleic acid and cholesterol. The lipid composition is uniform and stable, and is not limited before meals or empty stomach when being taken orally, so that the compliance and safety of medication of patients are improved. Meanwhile, the encapsulation efficiency of temozolomide is also obviously improved.